Chemical and perfusion markers as predictors of moyamoya disease progression and complication types

Jae Hyun Kim,Hanwool Jeon,Moinay Kim,Joonho Byun,Yeongu Chung,Si Un Lee,Wonhyoung Park,Jung Cheol Park,Jae Sung Ahn,Seungjoo Lee

DOI: https://doi.org/10.1038/s41598-023-47984-y

IF: 4.6

2024-01-02

Scientific Reports

Abstract:Abstract To investigate the association between chemical markers (triglyceride, C-reactive protein (CRP), and inflammation markers) and perfusion markers (relative cerebral vascular reserve (rCVR)) with moyamoya disease progression and complication types. A total of 314 patients diagnosed with moyamoya disease were included. Triglyceride and CRP levels were assessed and categorized based on Korean guidelines for dyslipidemia and CDC/AHA guidelines, respectively. Perfusion markers were evaluated using Diamox SPECT. Cox proportional hazard analysis was performed to examine the relationship between these markers and disease progression, as well as complication types (ischemic stroke, hemorrhagic stroke, and rCVR deterioration). Elevated triglyceride levels (≥ 200) were significantly associated with higher likelihood of end-point events (HR: 2.292, CI 1.00–4.979, P = 0.03). Severe decreased rCVR findings on Diamox SPECT were also significantly associated with end-point events (HR: 3.431, CI 1.254–9.389, P = 0.02). Increased CRP levels and white blood cell (WBC) count were significantly associated with moyamoya disease progression. For hemorrhagic stroke, higher triglyceride levels were significantly associated with end-point events (HR: 5.180, CI 1.355–19.801, P = 0.02). For ischemic stroke, severe decreased rCVR findings on Diamox SPECT (HR: 5.939, CI 1.616–21.829, P < 0.01) and increased CRP levels (HR: 1.465, CI 1.009–2.127, P = 0.05) were significantly associated with end-point events. Elevated triglyceride, CRP, and inflammation markers, as well as decreased rCVR, are potential predictors of moyamoya disease progression and complication types. Further research is warranted to understand their role in disease pathophysiology and treatment strategies.

multidisciplinary sciences

What problem does this paper attempt to address?

The problem this paper attempts to address is the exploration of the association between chemical markers (triglycerides, C-reactive protein, and inflammatory markers) and perfusion markers (relative cerebrovascular reserve, rCVR) in the progression and complication types of Moyamoya disease (MMD).

Specifically:
1. **Chemical Markers**: The study investigated the relationship between triglyceride levels and inflammatory markers such as C-reactive protein (CRP) with the progression of Moyamoya disease.
2. **Perfusion Markers**: The relative cerebrovascular reserve (rCVR) was assessed using Diamox SPECT to understand its relationship with disease progression.
3. **Complication Types**: The predictive role of different markers for ischemic stroke, hemorrhagic stroke, and rCVR deterioration was analyzed.

Research findings:
- High triglyceride levels (≥ 200 mg/dL) significantly increased the risk of endpoint events.
- Severe rCVR reduction was also associated with a higher risk of endpoint events.
- Elevated CRP levels and white blood cell counts were related to the progression of Moyamoya disease.
- For hemorrhagic stroke, high triglyceride levels were significantly associated; for ischemic stroke, severe rCVR reduction and elevated CRP levels were significantly associated.

These findings suggest that chemical markers such as triglycerides, CRP, and inflammatory markers, as well as the reduction of rCVR, may be potential predictors of the progression and complication types of Moyamoya disease. Future research will further explore the role of these markers in the pathophysiology and treatment strategies of the disease.